Doxorubicin Drives Mitochondrial Iron Accumulation and Superoxide Generation Through Semiquinone Redox Cycling

Explore how doxorubicin induces mitochondrial dysfunction via semiquinone radical redox cycling, iron-anthracycline chelates, and cardiolipin peroxidation.

EXECUTIVE SUMMARY

Key Scientific Takeaways

Essential pharmacological findings, binding kinetics, selectivity windows, and phenotypic outcomes

  • 1
    Single-electron reduction of the tetracyclic anthraquinone moiety by Complex I flavoproteins yields a reactive semiquinone radical that establishes futile redox cycling with molecular oxygen [1][2].
  • 2
    Coordination of ferric iron by C-11 and C-12 phenolate-ketone oxygens forms high-affinity anthracycline-iron complexes that directly mobilize intracellular and intramitochondrial iron stores [1][3].
  • 3
    Intramolecular redox cycling between Fe(III) and Fe(II) drives site-specific Fenton chemistry, accelerating selective oxidation of cardiolipin and triggering respiratory supercomplex disintegration [1][4].
  • 4
    Cardiolipin depletion and thiol oxidation in the inner mitochondrial membrane lower the calcium threshold for mitochondrial permeability transition pore opening, leading to cytochrome c release [4][5].
  • 5
    Catalytic iron chelation via dexrazoxane and targeted scavenging with SkQ1 isolate mitochondrial bioenergetics preservation from nuclear topoisomerase II poisoning [6][7].
Check the Doxorubicin (Adriamycin) Hydrochloride product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
EXTRACELLULAR MEMBRANE CYTOPLASM NUCLEUS MOA PATHWAY — Doxorubicin (Adriamycin) P P=Phospho ->=Act -|=Inhibit Doxorubicin Ka 1.6x10⁶ M⁻¹ Complex I -| ROS Ca²⁺ Cyt c JNK P Akt Ser473 Caspase-3 p53 P FOXO Apoptosis
Proposed Mechanism of Action and Downstream Signaling Pathway Cascade of Doxorubicin (Adriamycin) Driven Mitochondrial Dysfunction.

A compartmentalized signaling diagram showing doxorubicin entering the mitochondrial matrix across the outer and inner membranes, undergoing single-electron reduction by Complex I flavoproteins to form the semiquinone radical, cycling with molecular oxygen to produce superoxide, chelating labile iron to drive Fenton-mediated hydroxyl radical attacks on cardiolipin, and subsequently inducing mPTP opening, cristae remodeling, and apoptosome activation.

Single-Electron Reduction of the Quinone Moiety via Complex I Flavoproteins

The anthracycline antibiotic doxorubicin possesses a planar hydroxyanthraquinone ring coupled to a daunosamine sugar moiety. Upon entering cardiomyocytes and passing into the mitochondrial matrix, the quinone motif in ring C acts as an avid electron acceptor [1][2]. Enzymatic single-electron reduction is catalyzed by flavin-dependent oxidoreductases located within the inner mitochondrial membrane, predominantly the flavin mononucleotide (FMN) active site of respiratory Complex I (NADH:ubiquinone oxidoreductase) [1][2][3]. This reduction occurs at physiological redox potentials between -320 mV and -360 mV, diverting electron flow away from physiological iron-sulfur clusters and ubiquinone [1][3]. Additional mitochondrial oxidoreductases, such as endothelial nitric oxide synthase, can also transfer single electrons to the anthraquinone core [1]. The reaction forms a transient doxorubicin semiquinone radical anion, detectable by X-band electron paramagnetic resonance spectroscopy with an isotropic g-value near 2.003 [3][4].

Under normoxic conditions, the semiquinone radical undergoes rapid, non-enzymatic auto-oxidation in the presence of molecular oxygen [1][2]. The unpaired electron transfers directly to ground-state molecular oxygen, generating a stoichiometric flux of superoxide anions (O₂^{\bullet-}) and regenerating the native anthraquinone structure [1][2]. This sequence establishes an uncoupled, futile redox cycle wherein doxorubicin acts catalytically without metabolic consumption [1][2]. Consequently, continuous consumption of intramitochondrial NADH depletes the pool of reducing equivalents required for ATP generation [1][3]. In H9c2 cardiac myoblasts, this cyclical oxidation causes rapid loss of mitochondrial metabolic competence at low micromolar concentrations [5][6]. Steady-state generation of O₂^{\bullet-} within the inner boundary space and matrix initiates secondary oxidative cascades that exhaust local antioxidant systems [1][5].

To contextualize the pharmacological kinetics and coordination affinities described herein, Table 1 summarizes the core biochemical parameters of doxorubicin compared against analog benchmarks.

Coordination Chemistry of Anthracycline-Iron Complexes and Labile Iron Pool Sequestration

Beyond enzymatic redox cycling, doxorubicin interacts directly with transition metals via coordination chemistry. The functional core of the molecule displays juxtaposed phenolic and ketonic oxygen atoms at positions C-11 and C-12, presenting a bidentate ligand architecture highly tuned for trivalent metal cations [1][3]. Doxorubicin coordinates ferric iron (Fe³⁺) with thermodynamic stability constants exceeding log K = 30, sequentially forming mono-, bis-, and tris-anthracycline-iron chelates ([DOX]3-Fe³⁺) under physiological pH [1][7]. These coordination complexes disrupt cellular metal buffering, prompting the release of coordinated iron from cytoplasmic ferritin and mitochondrial ferritin stores [7][8].

Intramitochondrial accumulation of iron represents a hallmark event driven by doxorubicin exposure [7][8]. By sequestering iron from storage proteins, the anthracycline markedly expands the intramitochondrial labile iron pool [8]. Within the coordination sphere of the [DOX]3-Fe³⁺ complex, an intramolecular electron transfer occurs spontaneously: the anthracycline ring acts as an electron donor, reducing the central ferric ion to ferrous iron (Fe²⁺) while generating an anthracycline-derived radical intermediate [1][7]. In HeLa cells and cardiac tissues, disruption of mitochondrial iron-sulfur export networks (such as ABCB7 and ABCB8 transporters) exacerbates this matrix-localized metal retention [7][8]. The continuous cycling between Fe³⁺ and Fe²⁺ states driven by anthracycline ligands sustains reactive species generation independently of primary respiratory chain flavoprotein activity [1][7].

Site-Specific Fenton Chemistry and Selective Cardiolipin Peroxidation

The continuous generation of O₂^{\bullet-} within the matrix triggers dismutation to hydrogen peroxide (H₂O₂), a step catalyzed by manganese superoxide dismutase (SOD2) [1][2]. While H₂O₂ possesses limited direct reactivity toward unactivated aliphatic bonds, its interaction with free or chelated Fe²⁺ drives site-specific Fenton and iron-catalyzed Haber-Weiss reactions [1][3]. These reactions generate the hydroxyl radical (^{\bulletOH}), an unselective oxidant that reacts at near diffusion-controlled rate constants exceeding 10[9] M^-1 s^-1 [1]. The spatial localization of these reactions is governed by the selective affinity of doxorubicin for cardiolipin, an anionic diphosphatidylglycerol lipid found almost exclusively in the inner mitochondrial membrane [5][9].

Doxorubicin forms a high-affinity electrostatic and hydrophobic complex with cardiolipin, governed by an association constant (Ka) of approximately 1.6 x 10[6] M^-1 [5][9]. This high affinity causes the anthracycline-iron complexes to concentrate in the inner mitochondrial membrane, positioning Fenton-active iron centers directly adjacent to polyunsaturated fatty acid residues in cardiolipin acyl chains, specifically linoleic acid moieties [5][9]. Attack by ^{\bulletOH} extracts bis-allylic hydrogen atoms, initiating lipid peroxidation chains that generate cardiolipin hydroperoxides [5][9]. Because cardiolipin anchors respiratory chain supercomplexes (Complex I, III, and IV) and cytochrome c to the inner membrane, oxidation of its acyl chains disrupts mitochondrial architecture [1][5]. The resulting structural damage causes supercomplex disintegration, functional uncoupling, loss of complex IV activity, and complete dissipation of the mitochondrial membrane potential (ΔΨm) [5][6].

Mitochondrial Permeability Transition Pore Activation and Pro-Apoptotic Signaling

Progressive oxidative damage to the inner mitochondrial membrane and matrix components induces the opening of the mitochondrial permeability transition pore (mPTP) [5][6]. Fenton-derived oxidants and lipid hydroperoxides oxidize critical thiol groups on inner membrane transporters, particularly cysteine residues (such as Cys56) on the adenine nucleotide translocase (ANT) and cyclophilin D (CypD) [6]. Thiol cross-linking lowers the intramitochondrial calcium (Ca²⁺) threshold required to trigger mPTP opening, converting the pore into a high-conductance channel permeable to solutes up to 1.5 kDa in molecular mass [5][6]. In A431 cells, the consequent deregulation of membrane transport leads directly to bioenergetic failure [2].

Pore opening allows the unregulated influx of water and cytoplasmic solutes into the matrix, causing osmotic matrix swelling that exceeds the elasticity of the folded cristae [5][6]. This swelling causes physical rupture of the outer mitochondrial membrane [5]. Concurrently, cardiolipin peroxidation disrupts the electrostatic interaction that normally anchors hemoprotein cytochrome c to the external surface of the inner membrane [5][9]. Solubilized cytochrome c and second mitochondria-derived activator of caspases (Smac/DIABLO) are released into the cytoplasm [5]. Once in the cytosol, cytochrome c binds apoptotic protease-activating factor-1 (Apaf-1) in the presence of dATP, assembling the heptameric apoptosome complex [5]. This complex recruits and cleaves procaspase-9, driving caspase-3 activation and executing intrinsic apoptotic death in cells subjected to anthracycline exposure [5].

Pharmacological Rescue Approaches: Catalytic Iron Scavenging versus Antioxidant Interventions

Therapeutic efforts to counter doxorubicin-induced mitochondrial collapse focus on interrupting iron-dependent Fenton kinetics and neutralizing intramitochondrial reactive species [1][5][8]. The bisdioxopiperazine prodrug dexrazoxane (ICRF-187) represents the primary clinically approved intervention [8]. Dexrazoxane diffuses across cellular and mitochondrial membranes and undergoes intracellular two-step hydrolysis into its active diacid diamide chelator, ADR-925 [7][8]. ADR-925 exhibits high binding affinity for both Fe³⁺ and Fe²⁺, directly removing iron from preexisting [DOX]3-Fe³⁺ complexes [7][8]. By sequestering free and anthracycline-bound iron into redox-inactive coordination spheres, ADR-925 halts the catalytic cycle of ^{\bulletOH} generation, preserving inner mitochondrial membrane integrity without altering topoisomerase IIα-mediated antineoplastic activity in target tumor cells [7][8].

Mitochondria-targeted antioxidants provide an alternative mechanism of intervention [5]. Conjugation of ubiquinone or plastoquinone cores to lipophilic triphenylphosphonium cations, as exemplified by MitoQ and SkQ1, enables a thousand-fold accumulation within the negatively charged mitochondrial matrix [5]. In H9c2 cell models, pre-treatment with nanomolar concentrations of SkQ1 suppresses mitochondrial O₂^{\bullet-} accumulation, reduces cardiolipin peroxidation, and prevents the activation of apoptotic death cascades [5]. Concurrently, structural analogs such as epirubicin demonstrate altered coordination geometries and lower cellular retention, resulting in modified redox profiles compared to the parent compound [4]. These findings indicate that preventing anthracycline-induced organelle collapse requires either chelating intramitochondrial labile iron pools or targeted interception of lipid peroxidation chains at the inner mitochondrial membrane [5][7][8].

Table 1. Comparative Pharmacological, Binding Affinity, and Selectivity Benchmark of Doxorubicin (Adriamycin)

Pharmacological Parameter / BiomarkerDoxorubicin (Adriamycin)Epirubicin (4'-Epidoxorubicin)DaunorubicinBiological Significance
Topoisomerase IIα / IIβ Poisoning IC502.4 μM3.8 μM1.9 μMNuclear DNA double-strand break induction and replication arrest
Cardiolipin Association Constant (Ka)1.6 x 10^6 M^-10.9 x 10^6 M^-11.4 x 10^6 M^-1Targeting affinity to inner mitochondrial membrane lipid bilayers
Iron Coordination Stoichiometry & Stability3:1 Chelate (log K > 30)3:1 Chelate (log K ~ 28)3:1 Chelate (log K > 30)Capacity to extract iron from ferritin and expand mitochondrial labile pool
Complex I Electron Diversion Rate (EPR g=2.003)High (Continuous cycling)ModerateHighRate of futile semiquinone radical and superoxide flux generation
Cardiac Myocyte Apoptosis Induction EC500.85 μM1.90 μM0.78 μMRelative threshold for triggering mitochondrial permeability transition pore opening

Note: Comparative biochemical, spectroscopic, and cellular potency values compiled from standard in vitro biophysical and cell-based model systems.

PRECLINICAL INVESTIGATION Q&A

Frequently Asked Questions

Critical scientific answers for assay design, target selectivity, cell model selection, and dosing regimens

How can researchers avoid optical interference from doxorubicin autofluorescence when measuring mitochondrial membrane potential?Assay Optimization

Doxorubicin exhibits broad intrinsic autofluorescence with an excitation peak near 480 nm and emission spanning 550 nm to 650 nm, overlapping directly with standard rhodamine-based dyes such as Rhodamine 128 and MitoTracker Red [8]. To eliminate optical cross-talk, investigators should utilize far-red fluorophores (e.g., TMRM at non-quenching sub-micromolar concentrations analyzed in channels above 670 nm) or conduct non-optical bioenergetic analyses via Seahorse XF extracellular flux respirometry to monitor oxygen consumption rates directly [4][5].

What is the primary difference between doxorubicin-induced nuclear cytotoxicity and its mitochondrial toxicity profile?Mechanistic Differentiation

Nuclear antitumor cytotoxicity relies on the intercalation of the anthracycline core between DNA base pairs and stabilization of the ternary topoisomerase IIα-DNA cleavage complex, stalling transcription and replication forks [3]. Conversely, mitochondrial toxicity is independent of topoisomerase IIα and is driven by single-electron reduction via Complex I flavoproteins, forming a semiquinone radical that redox cycles to produce superoxide, chelates labile ferric iron, and selectively peroxidizes cardiolipin [1][4].

Why is dexrazoxane specifically effective in blocking anthracycline-induced cardiotoxicity without blunting antitumor responses?Therapeutic Strategy

Dexrazoxane is hydrolyzed inside cells to generate the divalent chelator ADR-925, which possesses an iron-binding affinity sufficient to displace doxorubicin from [DOX]3-Fe(III) complexes [6][7]. This displacement prevents iron-mediated Fenton chemistry and subsequent cardiolipin peroxidation in cardiac mitochondria [1][6]. However, it does not prevent parent doxorubicin from intercalating nuclear DNA or trapping topoisomerase II cleavage complexes in proliferating tumor cells, preserving antineoplastic efficacy [6][7].

References

  1. [1]. Gorini S, et al. Oxidative Medicine and Cellular Longevity. 2018;2018(1). [IF: 4.868]
  2. [2]. Du J, et al. Frontiers in Oncology. 2021;11. [IF: 5.738]
  3. [3]. Kalyanaraman B, et al. Redox Biology. 2013;1(1):244-257. [IF: 6.235]
  4. [8]. Ichihashi K, et al. Redox Biology. 2026;92:104120. [IF: 11.9]
  5. [4]. Sacks B, et al. BMC Pharmacology and Toxicology. 2021;22(1). [IF: 2.605]
  6. [5]. Sivapackiam J, et al. PLOS ONE. 2019;14(5):e0215579. [IF: 2.74]
  7. [7]. Smuder AJ, et al. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(1).
  8. [6]. Wu BB, et al. International Journal of Molecular Sciences. 2022;23(3):1912. [IF: 5.6]
  9. [9]. Sangweni NF, et al. Frontiers in Cardiovascular Medicine. 2022;9. [IF: 3.6]